Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Transperineal interstitial implantation of prostate cancer: a new method. [X-ray; radon seed implant]

Conference · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)
OSTI ID:6784118
A method of transperineal interstitial implant of prostate without the need for surgical exploration was used to provide a boost dose of 3200 rad to the implanted volume in patients with relatively advanced Stage C carcinoma of the prostate. All patients were initially given megavoltage teletherapy to a dose of 4320 rad in 24 treatments. Disease was locally controlled among all patients except one (96%). The morbitity was insignificant and the quality of life was good. The time of recurrence was from three to nine months in the seven patients who failed. No patient among those initially diagnosed by needle biopsy had failed whereas 50% of those whose diagnosis was by transurethral resection showed distant metastases.
Research Organization:
Univ. of Miami School of Medicine, FL
OSTI ID:
6784118
Conference Information:
Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Journal Volume: 6:9
Country of Publication:
United States
Language:
English

Similar Records

Ultrasonically guided 125iodine seed implantation with external radiation in management of localized prostatic carcinoma
Journal Article · Sun Oct 01 00:00:00 EDT 1989 · Urology (Ridgewood, N.J.); (USA) · OSTI ID:5225885

Transperineal 125-iodine endocurietherapy of prostate cancer
Journal Article · Mon Aug 01 00:00:00 EDT 1988 · Am. J. Clin. Oncol.; (United States) · OSTI ID:6802280

Percutaneous transperineal placement of gold 198 seeds for treatment of carcinoma of the prostate
Journal Article · Wed Dec 31 23:00:00 EST 1986 · Prostate (N.Y.); (United States) · OSTI ID:5625624